Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to get the job done. It makes me chuckle when I see modern medications that have little or nothing to do with tear volume evaluate…
‘A historic moment’: Medical societies unite at Lifestyle Medicine Conference
DALLAS — Leaders of several medical organizations came together at the American College of Lifestyle of Medicine’s annual conference to highlight the importance of integrating lifestyle medicine across all of health care.Padmaja Patel, MD, DipABLM, FAC…
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
MILAN–(BUSINESS WIRE)– #Biotech–On the heels of AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated v…
Practices need to prepare for new technology
Click here to read the Cover Story, “Digital future of ophthalmology is now.”As ophthalmology practices continue to embrace digital transformation, one of the greatest challenges is not the technology itself — it is managing expectations.That might sou…
Practices need to prepare for new technology
Click here to read the Cover Story, “Digital future of ophthalmology is now.”As ophthalmology practices continue to embrace digital transformation, one of the greatest challenges is not the technology itself — it is managing expectations.That might sou…
VIDEO: Late-stage wet AMD assets garner excitement at AAO
ORLANDO — In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that tyrosine kinase inhibitors and gene therapy progr…